Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease通过组胺H3受体调节多巴胺D1受体是亨廷顿舞蹈病的新治疗靶点ELIFEIF02020-06-0929OA
Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do notLIFE SCIENCE ALLIANCEIF2.92020-03-2523OAAI
Design and development of stapled transmembrane peptides that disrupt the activity of G-protein?coupled receptor oligomersJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92019-11-0123OAAI
Site-Specific Encoding of Photoactivity in Antibodies Enables Light-Mediated Antibody-Antigen Binding on Live CellsANGEWANDTE CHEMIE-INTERNATIONAL EDITIONIF16.92019-10-3128OAAI
A Positive Allosteric Modulator of the Serotonin 5-HT2c Receptor for ObesityJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-11-1731OAAI
A new serotonin 5-HT6 receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the bindingSCIENTIFIC REPORTSIF3.92017-01-2442OAAI
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal StriatumNEUROPSYCHOPHARMACOLOGYIF7.12017-01-1954OAAI
TARGETING DOPAMINE D1-HISTAMINE H3 RECEPTOR HETEROMERS AS A THERAPEUTICAL STRATEGY TO PREVENT COGNITIVE DEFICITS AND NEURODEGENERATION IN HUNTINGTON'S DISEASEJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYIF7.52014-09-170PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向